Invention Grant
- Patent Title: Treatment of neurodegenerative disease with sodium chlorite
-
Application No.: US18441621Application Date: 2024-02-14
-
Publication No.: US12109231B2Publication Date: 2024-10-08
- Inventor: Vernon A. Norviel , Michael S. McGrath
- Applicant: Neuvivo, Inc. , The Regents of the University of California
- Applicant Address: US CA Palo Alto
- Assignee: NEUVIVO, INC.,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee: NEUVIVO, INC.,THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
- Current Assignee Address: US CA Palo Alto; US CA Oakland
- Agency: WILSON SONSINI GOODRICH & ROSATI
- Main IPC: A61K33/20
- IPC: A61K33/20 ; A61P25/28

Abstract:
The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
Public/Granted literature
- US20240261326A1 TREATMENT OF NEURODEGENERATIVE DISEASE WITH SODIUM CHLORITE Public/Granted day:2024-08-08
Information query